Mizuho analyst Vijay Rakesh just raised his price target on Micron. Micron generates a lot less cash than its earnings suggest. Micron shares sell for a tiny P/E ratio -- but a gigantic valuation on P ...

SIOUX CITY (KTIV) - The Neonatal Intensive Care Unit (NICU) at UnityPoint Health-St. Luke’s has received a new Level 3 designation, and the hospital says this will allow them to help more infants and ...

Thanks in large part to the all-around prowess of potential Duke basketball recruiting pledge Jordan Smith Jr., the Paul VI Catholic High School (Va.) Panthers (11-1) haven't lost a game in almost ...

Last week, bulls needed to hold closes above $85,000 to stave off the bears, and they managed to do just that. Bitcoin price dropped to support once again last week, and the bulls defended it well, ...

End-of-Mission press releases include statements of IMF staff teams that convey preliminary findings after a visit to a country. The views expressed in this statement are those of the IMF staff and do ...

Baldur's Gate Larian lead has a little 'crash out on main' over Baldur's Gate 3 show announce, but big boss Swen Vincke says HBO is in touch about the writing, so now I don't know what to think AI 'We ...

Bitcoin traders braced for a major move “around the corner” after days of BTC price action sticking to a tight range around $90,000. Bitcoin is seen breaking its sideways trading range as volatility ...

Analyst ratings play a steady role in how traders interpret a stock’s outlook. An upgrade, a downgrade or a revised price target often sets the tone for short-term sentiment, and the reaction can be ...

Mumbai, Dec 5 (PTI) Reserve Bank Governor Sanjay Malhotra on Friday said the central bank does not target any band for the rupee in the forex market, and allows the domestic currency to find its own ...

Bitcoin BTC $89,299.49 is down 30% from its October all-time high of $126,250 and down 17% in November, which is the joint worst month of 2025 and the weakest monthly performance since June 2022.

Diccon Hyatt is an experienced financial and economics reporter. He's written hundreds of articles breaking down complex financial topics in plain language, emphasizing the impact that economic ...

In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has aggressively blocked competition for it. By Rebecca Robbins With a sticker price ...